Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

First Edition

Research Article November 7 2025
Mezigdomide Combined with Bortezomib Disrupts Cell Cycle and Elicits Superior Anti-Tumor Effects in Multiple Myeloma
Chad C. Bjorklund,Marta Larrayoz,Jian Kang,Hsiling Chiu,Natasha Shtraizent,Lei Wu,Shirong Li,Chih-Chao Hsu,Junfei Zhao,Michael Amatangelo,Tracy Chow,Krista Wollerman,Ram Kumar Singh,Sneha Sridhara,Shailesh Dudhgaonkar,Prakash Subramanyam,Kaushik Ghosh,Paul G. Richardson,Nizar J. Bahlis,Anjan Thakurta,Jose A. Martinez-Climent,Anita K. Gandhi,Patrick R. Hagner
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article November 6 2025
Adapted physical activity for hematology inpatients: focus on lean mass gain
Axel Sudria,Michael Loschi,Andrea Pinto,Laura Crousse,Sami Benachour,Rinzine Sammut,Frederic Chorin,Nicolas Mounier,Thomas Cluzeau
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article November 6 2025
Impact of European LeukemiaNet (ELN) guided post-remission therapy on outcome of patients with AML from 2010-2022
Andrew F. Berdel,Julian Ronnacker,Daniela V. Wenge,Lina J. Kolloch,Philipp Berning,Linus Angenendt,Tobias J. Brix,Annette Westermann,Klaus Wethmar,Torsten Kessler,Andrea Kerkhoff,Rolf M. Mesters,Christian Reicherts,Jan-Henrik Mikesch,Wolfgang E. Berdel,Georg Lenz,Christoph Schliemann,Matthias Stelljes
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article November 6 2025
Ratios of CD8 T Lymphocytes to M-MDSCs (CD8MMR) Predict Prognosis in Untreated DLBCL Patients
Hao-Yuan Wang,Fu-Chen Yang,Ching-Fen Yang,Chun-Kuang Tsai,Po-Chun Liu,Po-Shen Ko,Yao-Chung Liu,Jyh-Pyng Gau,Jin-Hwang Liu,Po-Min Chen,Nien-Jung Chen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article November 6 2025
Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors
Alex C.H. Liu,Severine Cathelin,Dhanoop Manikoth Ayyathan,Yitong Yang,Farzaneh Aboualizadeh,Amina Abow,Gurbaksh Basi,Lance Li,David L. Dai,Abdula Maher,Eric Grignano,Mohsen Hosseini,Vivian Wang,Troy Ketela,Brandon Nicolay,Dylan M. Marchione,Adriana E. Tron,Andrea Arruda,Mark D. Minden,Steven M. Chan
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 27 2025
EXTENDED LONG TERM FOLLOW UP AND THE SURVIVAL OF STOP IMATINIB STUDY (STIM1)
François-Xavier Mahon,Stéphanie Dulucq,Delphine Réa,Franck Nicolini,Françoise Rigal-Huguet,Katerina Machova Polakova,Viviane Dubruille,Marie-Pierre Noel,Jean-Christophe Ianotto,Bruno Villemagne,Émilie Cayssials,Sophie Park,Philippe Rousselot,Gabriel Etienne
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 24 2025
PHASE Ib PILOT STUDY OF ITACITINIB WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA
Tapan M. Kadia,Akhil Jain,Caitlin R. Rausch,Alex Bataller,Farhad Ravandi,Elias Jabbour,Wei Qiao,Gautam Borthakur,Nicholas Short,Guillermo Montalban-Bravo,Andres E. Quesada,Jan Burger,Alessandra Ferrajoli,William Wierda,Chitra Hosing,Hagop Kantarjian
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 24 2025
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas
Julio C. Chavez,Ellen Napier,Attilio Bondanza,Andrew Lewandowski,Jennifer Mataraza,David Quinn,Paul Kwon,Frederick L. Locke,Boris Engels,Rakesh Awasthi,Petrina Georgala,Malgorzata Leyk,David Hynds,Michele Moschetta,Stephen J. Schuster
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 24 2025
Dual FLT3/PIM inhibitor dapolsertib (MEN1703) in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial
Giovanni Martinelli,Scott R. Solomon,Sudipto Mukherjee,Armando Santoro,Stephen A. Strickland,Susana Vives,Farhad Ravandi,Roland B. Walter,Rachel J. Cook,Ewa Lech-Maranda,Maria Calbacho,Agnieszka Wierzbowska,Giovanni Marconi,Evelyn Acuña-Cruz,Isabel Cano-Ferri,Francesco Bertolini,Tomasz Rzymski,Alessandro Paoli,Giovanni Marino Merlo,Faten Koraichi Auriol,Sonia Zicari,Antonio Galleu,Ira Gupta,Pau Montesinos
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 16 2025
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response
Anna Maria Corsale,Mojtaba Shekarkar Azgomi,Emilia Gigliotta,Marta Di Simone,Paola Pacelli,Francesca Cioffi,Elena Bestoso,Donatella Raspadori,Alessandro Gozzetti,Antonio Solimando,Paula Tabares,Andreas Beilhack,Maria Speciale,Giusy Corsale,Miriam Sciortino,Cristina Aquilina,Fulvio Brucato,Michele Cea,Renato Zambello,Francesca Garofano,Marta Biondo,Francesca Buffa,Nadia Caccamo,Francesco Dieli,Serena Meraviglia,Sergio Siragusa,Cirino Botta
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 9 2025
Safety of Gemtuzumab Ozogamicin with Cytarabine, Daunorubicin, and Midostaurin Induction in FLT3-Mutated AML
Jayanshu Jain,Kelly Pugh,Shivani Handa,Kaitlyn M Dvorak-Kornaus,Qiuhong Zhao,Roland B Walter,Rachel Cook,Jennifer Saultz,Ronan Swords,Junyang Li,George S. Laszlo,Nicole R Grieselhuber,Alice S Mims,Karilyn T M Larkin,Kieran Sahasrabudhe,James S Blachly,Gregory K Behbehani,Ann-Kathrin Eisfeld,Meixiao Long,Andrew Srisuwananukorn,Kristin L Koenig,Uma Borate
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article October 9 2025
Targeting Dysregulated Epigenetic and Transcription Factor Networks in KMT2A-Rearranged AML Using iPSC Models
Anna Palau,Jonas Thier,Aonghus Naughton,Andrew Tae-Jun Kwon,David Cabrerizo Granados,Sophia Hofmann,Bogumił Kaczkowski,Xiangfu Zhong,Sören Lehmann,Erik Arner,Vanessa Lundin,Andreas Lennartsson
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Brief Report October 9 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W Merryman,Justin Kline,Robert A. Redd,Harrison Olszewski,Emma Welsh,Kathleen Pfaff,Hannah Lee,Mikaela McDonough,Inhye E. Ahn,Jennifer R. Brown,Jennifer L. Crombie,Matthew S. Davids,David C. Fisher,Eric D Jacobsen,Caron A. Jacobson,Austin I. Kim,Oreofe O. Odejide,Erin Michelle Parry,Christine E. Ryan,Margaret A. Shipp,Philippe Armand,Scott Rodig,Jeremy S. Abramson,Ann S. LaCasce
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 

Advertisement intended for health care professionals

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals